journal article·2018-11-12Open access

A comparative study of stability, antioxidant, DNA cleavage and antibacterial activities of green and chemically synthesized silver nanoparticles

Mohammad Mousavi-Khattat, Mehrnaz Keyhanfar, Amir Razmjou

Abstract

Silver nanoparticles have a wide range of research, industrial and biomedical applications that make it essential to develop a low cost and eco-friendly approach with scaling up potential. Green synthesis of nanoparticles through bio-reactions leads to a reduction of silver ions to particles could be an acceptable selection using no additional reducing chemicals. Moreover, the simplicity of scale-up processes of the method makes it more efficient than chemical and physical synthesis methods. In this study, Datura stramonium leaf extract and sodium citrate were used as biological and chemical reducing and stabilizing agents to make silver nanoparticles. The main goal is to comprise properties and evaluate antibacterial activity of nanoparticles synthesized through two approaches. Size and morphology compared between the two types of the synthesized nanoparticle by UV-Visible spectroscopy, DLS, AFM, TEM and their antibacterial effects were evaluated through growth inhibition MIC and MBC methods. The results showed narrow size range, spherical shape, high anti-oxidant, antibacterial and DNA cleavage activities of green synthesized silver nanoparticles comparing to less average size, wider range of nanoparticle size, no anti-oxidant activity and less antibacterial and DNA cleavage activities of chemically synthesized nanoparticles. The green synthesized silver nanoparticles had more desirable characteristics and biological activities compared to chemically synthesized nanoparticles. For instance, the green nanoparticles showed narrow size range, spherical shape, high anti-oxidant, antibacterial and DNA cleavage activities versus the chemically synthesized which had less average size, higher range of nanoparticles size, no anti-oxidant activity and less antibacterial and DNA cleavage activities.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biotechnology, University of Isfahan

References (61)

Show source-provided references
1. 10.2166/wh.2016.30410.2166/wh.2016.304 ↗
2. 10.1021/am500229v10.1021/am500229v ↗
3. 10.1039/C4NR06834C10.1039/C4NR06834C ↗
4. 10.2174/138920021866617011312513210.2174/1389200218666170113125132 ↗
5. 10.1038/srep0568610.1038/srep05686 ↗
6. 10.1021/jp026731y10.1021/jp026731y ↗
7. 10.1007/s11051-010-9900-y10.1007/s11051-010-9900-y ↗
8. Kim KJ, Sung WS, Moon SK, et al. Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol. 2008;18:1482–1484.
9. 10.1186/1477-3155-8-110.1186/1477-3155-8-1 ↗
10. 10.1016/j.colsurfb.2010.10.00810.1016/j.colsurfb.2010.10.008 ↗
11. 10.1557/JMR.2007.042010.1557/JMR.2007.0420 ↗
12. 10.1038/srep2041410.1038/srep20414 ↗
13. 10.3390/nano611020910.3390/nano6110209 ↗
14. 10.1016/j.toxlet.2007.10.00410.1016/j.toxlet.2007.10.004 ↗
15. 10.1016/j.cca.2010.08.01610.1016/j.cca.2010.08.016 ↗
16. 10.1016/j.toxlet.2009.07.00910.1016/j.toxlet.2009.07.009 ↗
17. 10.1093/jb/mvg11110.1093/jb/mvg111 ↗
18. 10.1038/srep2492910.1038/srep24929 ↗
19. 10.1080/1943085090293159910.1080/19430850902931599 ↗
20. 10.1016/0147-619X(92)90008-X10.1016/0147-619X(92)90008-X ↗
21. 10.1088/0957-4484/14/1/32110.1088/0957-4484/14/1/321 ↗
22. 10.1016/j.colsurfb.2005.11.02610.1016/j.colsurfb.2005.11.026 ↗
23. 10.1016/j.jare.2015.02.00710.1016/j.jare.2015.02.007 ↗
24. 10.32607/20758251-2014-6-1-35-4410.32607/20758251-2014-6-1-35-44 ↗
25. 10.1007/s00449-013-1091-310.1007/s00449-013-1091-3 ↗
26. 10.1016/j.colsurfa.2010.07.02010.1016/j.colsurfa.2010.07.020 ↗
27. 10.21010/ajtcam.v13i5.210.21010/ajtcam.v13i5.2 ↗
28. 10.1016/j.matlet.2014.02.00310.1016/j.matlet.2014.02.003 ↗
29. 10.1007/s00436-015-4710-x10.1007/s00436-015-4710-x ↗
30. 10.1016/S2221-1691(13)60014-310.1016/S2221-1691(13)60014-3 ↗
31. 10.1016/j.fitote.2004.10.00410.1016/j.fitote.2004.10.004 ↗
32. Reddy U. Antimicrobial activity of Datura stramonium L. and Tylophora indica (Burm.f.) Merr. Pharmacologyonline. 2009;1: 1293–1300.
33. 10.1016/j.chemosphere.2006.12.07110.1016/j.chemosphere.2006.12.071 ↗
34. 10.5897/JMPR2017.638110.5897/JMPR2017.6381 ↗
35. 10.1016/j.biomaterials.2003.10.07810.1016/j.biomaterials.2003.10.078 ↗
36. 10.2147/IJN.S13232710.2147/IJN.S132327 ↗
37. 10.1021/cm500316k10.1021/cm500316k ↗
38. 10.3109/1556365100363067210.3109/15563651003630672 ↗
39. 10.1016/j.nano.2009.01.01210.1016/j.nano.2009.01.012 ↗
40. CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, approved standard. 9th ed., Wayne, (PA): Clinical and Laboratory Standards Institute, 2012.
41. 10.1016/j.jpha.2015.11.00510.1016/j.jpha.2015.11.005 ↗
42. 10.1039/C7NJ02977B10.1039/C7NJ02977B ↗
43. 10.3390/ijerph1010522110.3390/ijerph10105221 ↗
44. 10.1021/nl050062t10.1021/nl050062t ↗
45. Kiruba Daniel SCG, Nazeema Banu B, Harshiny M, et al. Ipomea carnea-based silver nanoparticle synthesis for antibacterial activity against selected human pathogens. J Exp Nanosci. 2014;9:197–209.
46. 10.1007/s11051-017-3973-910.1007/s11051-017-3973-9 ↗
47. 10.1016/j.msec.2013.08.03910.1016/j.msec.2013.08.039 ↗
48. 10.1166/jbns.2009.100810.1166/jbns.2009.1008 ↗
49. 10.1039/C4CP02260B10.1039/C4CP02260B ↗
50. Halawani EM. Rapid biosynthesis method and characterization of silver nanoparticles using Zizyphus spina christi leaf extract and their antibacterial efficacy in therapeutic application. J Biomater Nanobiotechnol. 2017;8:22–35.
51. Ananth A, Rajan S. In-vitro antioxidant activity of Datura stramonium L. leaves. Advances in Applied Science Research. 2015;6:147–151.
52. 10.1038/s41598-018-20728-z10.1038/s41598-018-20728-z ↗
53. 10.1016/j.colsurfb.2012.04.00610.1016/j.colsurfb.2012.04.006 ↗
54. 10.1128/AEM.02001-0710.1128/AEM.02001-07 ↗
55. 10.1039/C4SC00138A10.1039/C4SC00138A ↗
56. 10.1038/s41598-017-15724-810.1038/s41598-017-15724-8 ↗
57. 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-310.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3 ↗
58. 10.3389/fmicb.2014.0022710.3389/fmicb.2014.00227 ↗
59. 10.1128/CMR.12.4.56410.1128/CMR.12.4.564 ↗
60. 10.1016/j.jpha.2015.01.00210.1016/j.jpha.2015.01.002 ↗
61. 10.1093/mutage/gev02010.1093/mutage/gev020 ↗